Related content

The place of pemetrexed in the management of non-small-cell lung cancer patients

By Tomasini Pascale   Greillier Laurent   Khobta Nataliya   Barlesi Fabrice  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 3, 2013-03 ,pp. : 257-266

Informa Healthcare

Access to resources Recommend Favorite

Afatinib in advanced non-small-cell lung cancer

By Di Maio Massimo   Gridelli Cesare   Grossi Francesco   Novello Silvia   de Marinis Filippo  

Lung Cancer Management, Vol. 2, Iss. 6, 2013-12 ,pp. : 493-504

Future Medicine

Access to resources Recommend Favorite

Role of Pemetrexed in Non-Small Cell Lung Cancer

By Longo-Sorbello Giuseppe   Chen Bobin   Budak-Alpdogan Tulin   Bertino Joseph  

Cancer Investigation, Vol. 25, Iss. 1, 2007-01 ,pp. : 59-66

Informa Healthcare

Access to resources Recommend Favorite

Expression of thymidylate synthase predicts clinical outcomes of pemetrexed-containing chemotherapy for non-small-cell lung cancer: a systemic review and meta-analysis

By Liu Yu   Yin Tie-Jun   Zhou Rong   Zhou Si   Fan Liang   Zhang Rong-Ge  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 1125-1132

Springer Publishing Company

Access to resources Recommend Favorite

Clinical observation of gemcitabine and concomitant three-dimensional conformal radiotherapy in the treatment of locally advanced non-small cell lung cancer

By Cheng Jing  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 6, 2008-06 ,pp. : 311-314

Springer Publishing Company

Access to resources Recommend Favorite